DLO Expands COVID-19 Testing Efforts
Diagnostic Laboratory of Oklahoma (DLO) began offering COVID-19 testing in Oklahoma on March 9 through Quest Diagnostics. As a joint venture of Quest Diagnostics and INTEGRIS Health, DLO is utilizing Quest’s laboratories in Dallas, Texas and San Juan Capistrano, Calif. DLO is now in the process of expanding its efforts by bringing up its own COVID-19 testing at its central laboratory in Oklahoma City to deliver more testing capacity to the state of Oklahoma.
DLO and OSDH Enter Into New Public-Private Partnership Expanding Oklahoma's Capacity for COVID-19 Tests
The Oklahoma State Department of Health (OSDH) today announced it has entered into a new public-private partnership with Diagnostic Laboratory of Oklahoma (DLO) to increase the State of Oklahoma’s capacity for delivering results for COVID-19 tests. As a result of the new partnership, more than 300 test specimens were immediately shipped yesterday to DLO’s facility in Dallas, Texas, for results within the next couple days.
DLO to Launch Coronavirus Disease 2019 (COVID-19) Testing
As a joint venture of Quest Diagnostics, Diagnostic Laboratory of Oklahoma (DLO) can provide testing for coronavirus (COVID-19) through Quest. Patients should be prioritized for testing of COVID-19 if they meet the CDC criteria, including those who may have been exposed to the virus or had contact with someone confirmed to have COVID-19, who show signs and symptoms (e.g., fever, cough, difficulty breathing), or who live in or recently traveled to a place where transmission of COVID-19 is prevalent.
DLO has been named a Preferred Lab Network Provider by UnitedHealthcare
Diagnostic Laboratory of Oklahoma (DLO), as a joint venture of Quest Diagnostics, is pleased to let you know that the following UnitedHealthcare Newsroom announcement was published on April 22, 2019.
UnitedHealthcare’s Triple Aim Focus Adding More Value for Lab Services
April 22, 2019
DLO acquires Cleveland HeartLab for Oklahoma
Diagnostic Laboratory of Oklahoma (DLO) has announced that it has completed its acquisition of Cleveland HeartLab business in Oklahoma.
